Snowball Research
Research hub for stocks under $5B
⌘K
Subscribe Sign in
activistcompany

Hoche Partners Criticizes Procaps (PROC) for Delayed Disclosures and Management Issues

Key Summary: On September 3, 2024, Hoche Partners criticized Procaps Group's press release for delaying disclosures, manipulating financials, and lacking investigation transparency. They condemned past management practices and questioned the effectiveness of the new CEO, suggesting Procaps might face bankruptcy without delayed bank payments.

Market Cap: $206 million | Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide.

parks-america-inc-prka-focused-compounding-fund

On Septembparks-america-inc-prka-focused-compounding-funder 3, 2024, Hoche Partners Pharma Holding S.A. criticized Procaps Group's hoche-partners-criticizes-procaps-proc-for-delayed-disclosures-and-management-issueshochoche-partners-criticizes-procaps-proc-for-delayed-disclosures-and-management-issueshe-partners-criticizes-procaps-proc-for-delayed-disclosures-and-management-issuesrecent press release, highlighting concerns over delayed disclosures, questionable management practices, and the lack of transparency regarding ongoing investigations. Hoche condemned the previous management’s practice of inflating sales and EBITDA figures through manipulated inventory and criticized the Board for opposing an independent investigation administrator. They also questioned the value added by the new CEO and expressed skepticism about the Company’s financial stability, suggesting that without delayed bank payments, Procaps might face bankruptcy. Source

Member discussion

More like this

Daniel J. Mangless nominated Board candidates to Zevra Therapeutics (ZVRA)

Key Summary: Daniel J. Mangless, who successfully elected three nominees to the Board at the 2023 AGM, filed proxy materials

H Partners Launches Withhold Campaign Against Harley-Davidson (HOG) Board

Key Summary: H Partners Management disclosed an 8% stake in Harley-Davidson in December 2021, raising concerns about executive compensation, governance,

Meruelo Offers Board Role After Discussing Debt Plans with Bausch Health Companies (BHC)

Key Summary: On March 31, 2025, Mr. Meruelo (9.99%) discussed debt refinancing and future plans with CEO Thomas Appio

Pontifax Management entered into a Letter Agreement with Keros Therapeutics, Inc (KROS)

Key Summary: On April 11, 2025, ADAR1 Capital called Keros undervalued but questioned the viability of KER-012 and KER-065, urging

The Founders Group, comprising Ransom and Valerie Wuller, Luis Dussan, and Pamela Bauer nominated Board candidates to AEye, Inc (LIDR)

Key Summary: On April 11, 2025, the Founders Group, comprising Ransom and Valerie Wuller, Luis Dussan, and Pamela Bauer nominated

Edge One Capital Management to Engage with BuzzFeed, Inc (BZFD)

Key Summary: On April 1, 2025, Edge One Capital Management (5.42%) announced plans to engage with BuzzFeed, Inc Market